Short-Term Investments

$5.54B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Short-Term Investments

Latest reported$5.54Bperiod endingJun 30, 2026

REGN Quarterly Short-Term Investments ($0.00 → $5.54B)

Quarterly short-term investments

High-resolution chart · PNG

REGN short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Short-Term Investments — Quarterly (USD)
Period ending	Short-Term Investments (USD)
Jun 30, 2026	5,538,800,000
Mar 31, 2026	5,791,100,000
Dec 31, 2025	5,487,100,000
Sep 30, 2025	5,937,200,000
Jun 30, 2025	5,473,800,000
Mar 31, 2025	5,259,200,000
Dec 31, 2024	6,524,300,000
Sep 30, 2024	7,784,700,000
Jun 30, 2024	7,888,300,000
Mar 31, 2024	7,917,500,000
Dec 31, 2023	8,114,800,000
Sep 30, 2023	7,761,300,000
Jun 30, 2023	6,990,500,000
Mar 31, 2023	5,043,400,000
Dec 31, 2022	4,636,400,000
Sep 30, 2022	3,530,400,000
Jun 30, 2022	4,171,300,000
Mar 31, 2022	3,704,900,000
Dec 31, 2021	2,809,100,000
Sep 30, 2021	2,355,200,000
Jun 30, 2021	1,838,600,000
Mar 31, 2021	2,065,900,000
Dec 31, 2020	1,393,300,000
Sep 30, 2020	1,452,900,000
Jun 30, 2020	1,152,000,000
Mar 31, 2020	1,795,200,000
Dec 31, 2019	1,596,500,000
Sep 30, 2019	1,493,100,000
Jun 30, 2019	1,624,200,000
Mar 31, 2019	1,523,900,000
Dec 31, 2018	1,342,200,000
Sep 30, 2018	1,104,309,000
Jun 30, 2018	765,642,000
Mar 31, 2018	605,461,000
Dec 31, 2017	596,847,000
Sep 30, 2017	586,879,000
Jun 30, 2017	523,537,000
Mar 31, 2017	495,311,000
Dec 31, 2016	503,481,000
Sep 30, 2016	488,032,000
Jun 30, 2016	398,656,000
Mar 31, 2016	244,965,000
Dec 31, 2015	236,121,000
Sep 30, 2015	241,055,000
Jun 30, 2015	213,694,000
Mar 31, 2015	234,257,000
Dec 31, 2014	251,761,000
Sep 30, 2014	395,650,000
Jun 30, 2014	216,774,000
Mar 31, 2014	186,275,000
Dec 31, 2013	158,376,000
Sep 30, 2013	182,112,000
Jun 30, 2013	155,831,000
Mar 31, 2013	127,348,000
Dec 31, 2012	77,819,000
Sep 30, 2012	143,554,000
Jun 30, 2012	129,079,000
Mar 31, 2012	37,713,000
Dec 31, 2011	43,332,000
Sep 30, 2011	39,103,000
Jun 30, 2011	55,371,000
Mar 31, 2011	91,065,000
Dec 31, 2010	136,796,000
Sep 30, 2010	153,767,000
Jun 30, 2010	194,337,000
Mar 31, 2010	186,328,000
Dec 31, 2009	134,255,000
Sep 30, 2009	129,475,000
Jun 30, 2009	120,452,000
Mar 31, 2009	216,785,000
Dec 31, 2008	226,954,000
Sep 30, 2008	348,924,000
Jun 30, 2008	408,275,000
Mar 31, 2008	222,373,000
Dec 31, 2007	267,532,000
Sep 30, 2007	299,566,000
Jun 30, 2007	351,054,000
Mar 31, 2007	295,910,000
Dec 31, 2006	221,400,000
Sep 30, 2006	94,227,000
Jun 30, 2006	158,616,000
Mar 31, 2006	120,061,000
Dec 31, 2005	114,037,000
Sep 30, 2005	131,449,000
Jun 30, 2005	190,612,000
Mar 31, 2005	206,090,000
Dec 31, 2004	194,748,000
Sep 30, 2004	173,668,000
Jun 30, 2004	221,217,000
Mar 31, 2004	146,702,000
Dec 31, 2003	175,489,000
Sep 30, 2003	86,056,000
Jun 30, 2003	144,215,000
Mar 31, 2003	120,404,000
Dec 31, 2002	184,194,000
Sep 30, 2002	224,317,000
Jun 30, 2002	229,331,000
Mar 31, 2002	189,601,000
Dec 31, 2001	137,686,000
Sep 30, 2001	140,735,000